V D Plat1, J P M Derikx2, A C Jongen3, K Nielsen4, D J A Sonneveld4, J J C Tersteeg5, R M P H Crolla5, D A van Dam6, H A Cense6, T G J de Meij7, J B Tuynman8, N K H de Boer9, F Daams8. 1. Department of Gastrointestinal Surgery, Amsterdam UMC, VU University Medical Center, De Boelelaan 1117, ZH 7F020, 1081 HV, Amsterdam, The Netherlands. V.plat@amsterdamumc.nl. 2. Department of Pediatric Surgery, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam and VU University Medical Center, Amsterdam, The Netherlands. 3. Department of Gastrointestinal Surgery, Maastricht University Medical Center, Maastricht, The Netherlands. 4. Department of Gastrointestinal Surgery, Dijklander ziekenhuis, Hoorn, The Netherlands. 5. Department of Gastrointestinal Surgery, Amphia ziekenhuis, Breda, The Netherlands. 6. Department of Gastrointestinal Surgery, Rode Kruis Ziekenhuis, Beverwijk, The Netherlands. 7. Department of Pediatric Gastroenterology and Hepatology, Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands. 8. Department of Gastrointestinal Surgery, Amsterdam UMC, VU University Medical Center, De Boelelaan 1117, ZH 7F020, 1081 HV, Amsterdam, The Netherlands. 9. Department of Gastroenterology and Hepatology, Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Anastomotic leakage (AL) remains a severe complication following colorectal surgery, having a negative impact on both short- and long-term outcomes. Since timely detection could enable early intervention, there is a need for the development of novel and accurate, preferably, non-invasive markers. The aim of this study was to investigate whether urinary intestinal fatty acid binding protein (I-FABP) could serve as such a marker. METHODS: This prospective multicenter cross-sectional phase two diagnostic study was conducted at four centers in the Netherlands between March 2015 and November 2016. Urine samples of 15 patients with confirmed colorectal AL and 19 patients without colorectal AL on postoperative day 3 were included. Urinary I-FABP levels were determined using enzyme-linked immunosorbent assays and adjusted for urinary creatinine to compensate for renal dysfunction. RESULTS: Urinary I-FABP levels were significantly elevated in patients with confirmed AL compared to patients without AL on postoperative day 3 (median: 2.570 ng/ml vs 0.809 ng/ml, p = 0.006). The area under the receiver operating characteristics curve (AUROC) was 0.775, yielding a sensitivity of 80% and specificity of 74% at the optimal cutoff point (> 1.589 ng/ml). This difference remained significant after calculation of I-FABP/creatinine ratios (median: 0.564 ng/µmol vs. 0.158 ng/µmol, p = 0.040), with an AUROC of 0.709, sensitivity of 60% and specificity of 90% at the optimal cutoff point (> 0.469 ng/µmol). CONCLUSIONS: Levels of urinary I-FABP and urinary I-FABP/creatinine were significantly elevated in patients with confirmed AL following colorectal surgery, suggesting their potential as a non-invasive biomarker for colorectal anastomotic leakage.
BACKGROUND: Anastomotic leakage (AL) remains a severe complication following colorectal surgery, having a negative impact on both short- and long-term outcomes. Since timely detection could enable early intervention, there is a need for the development of novel and accurate, preferably, non-invasive markers. The aim of this study was to investigate whether urinary intestinal fatty acid binding protein (I-FABP) could serve as such a marker. METHODS: This prospective multicenter cross-sectional phase two diagnostic study was conducted at four centers in the Netherlands between March 2015 and November 2016. Urine samples of 15 patients with confirmed colorectal AL and 19 patients without colorectal AL on postoperative day 3 were included. Urinary I-FABP levels were determined using enzyme-linked immunosorbent assays and adjusted for urinary creatinine to compensate for renal dysfunction. RESULTS: Urinary I-FABP levels were significantly elevated in patients with confirmed AL compared to patients without AL on postoperative day 3 (median: 2.570 ng/ml vs 0.809 ng/ml, p = 0.006). The area under the receiver operating characteristics curve (AUROC) was 0.775, yielding a sensitivity of 80% and specificity of 74% at the optimal cutoff point (> 1.589 ng/ml). This difference remained significant after calculation of I-FABP/creatinine ratios (median: 0.564 ng/µmol vs. 0.158 ng/µmol, p = 0.040), with an AUROC of 0.709, sensitivity of 60% and specificity of 90% at the optimal cutoff point (> 0.469 ng/µmol). CONCLUSIONS: Levels of urinary I-FABP and urinary I-FABP/creatinine were significantly elevated in patients with confirmed AL following colorectal surgery, suggesting their potential as a non-invasive biomarker for colorectal anastomotic leakage.
Authors: Kostan W Reisinger; Martijn Poeze; Karel W E Hulsewé; Bernadette A van Acker; Annemarie A van Bijnen; Anton G M Hoofwijk; Jan H M B Stoot; Joep P M Derikx Journal: J Am Coll Surg Date: 2014-06-25 Impact factor: 6.113
Authors: V D Plat; B T Bootsma; M Neal; K Nielsen; D J A Sonneveld; J J C Tersteeg; R M P H Crolla; D A van Dam; H A Cense; H B A C Stockmann; J A Covington; T G J de Meij; J B Tuynman; N K H de Boer; F Daams Journal: Colorectal Dis Date: 2019-07-21 Impact factor: 3.788
Authors: Geertje Thuijls; Kim van Wijck; Joep Grootjans; Joep P M Derikx; Annemarie A van Bijnen; Erik Heineman; Cornelis H C Dejong; Wim A Buurman; Martijn Poeze Journal: Ann Surg Date: 2011-02 Impact factor: 12.969
Authors: Joep P M Derikx; Anita C E Vreugdenhil; Anita M Van den Neucker; Joep Grootjans; Annemarie A van Bijnen; Jan G M C Damoiseaux; L W Ernest van Heurn; Erik Heineman; Wim A Buurman Journal: J Clin Gastroenterol Date: 2009-09 Impact factor: 3.062
Authors: Jennifer Straatman; Annelieke M K Harmsen; Miguel A Cuesta; Johannes Berkhof; Elise P Jansma; Donald L van der Peet Journal: PLoS One Date: 2015-07-15 Impact factor: 3.240
Authors: Jérémie F Cohen; Daniël A Korevaar; Douglas G Altman; David E Bruns; Constantine A Gatsonis; Lotty Hooft; Les Irwig; Deborah Levine; Johannes B Reitsma; Henrica C W de Vet; Patrick M M Bossuyt Journal: BMJ Open Date: 2016-11-14 Impact factor: 2.692
Authors: Marcel C G van de Poll; Joep P M Derikx; Wim A Buurman; Wilbert H M Peters; Hennie M J Roelofs; Stephen J Wigmore; Cornelis Hc Dejong Journal: World J Surg Date: 2007-10 Impact factor: 3.352